JP2021532110A5 - - Google Patents

Info

Publication number
JP2021532110A5
JP2021532110A5 JP2021503531A JP2021503531A JP2021532110A5 JP 2021532110 A5 JP2021532110 A5 JP 2021532110A5 JP 2021503531 A JP2021503531 A JP 2021503531A JP 2021503531 A JP2021503531 A JP 2021503531A JP 2021532110 A5 JP2021532110 A5 JP 2021532110A5
Authority
JP
Japan
Prior art keywords
pharmaceutical preparation
approximately
pharmaceutical formulation
pharmaceutical
physically stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021503531A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021532110A (ja
JP7399382B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/041609 external-priority patent/WO2020028011A1/en
Publication of JP2021532110A publication Critical patent/JP2021532110A/ja
Publication of JP2021532110A5 publication Critical patent/JP2021532110A5/ja
Priority to JP2023194827A priority Critical patent/JP7738046B2/ja
Application granted granted Critical
Publication of JP7399382B2 publication Critical patent/JP7399382B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021503531A 2018-07-30 2019-07-12 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤 Active JP7399382B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023194827A JP7738046B2 (ja) 2018-07-30 2023-11-16 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862711767P 2018-07-30 2018-07-30
US62/711,767 2018-07-30
PCT/US2019/041609 WO2020028011A1 (en) 2018-07-30 2019-07-12 Formulations for improved stability of recombinant human parathyroid hormone

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023194827A Division JP7738046B2 (ja) 2018-07-30 2023-11-16 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤

Publications (3)

Publication Number Publication Date
JP2021532110A JP2021532110A (ja) 2021-11-25
JP2021532110A5 true JP2021532110A5 (https=) 2022-07-21
JP7399382B2 JP7399382B2 (ja) 2023-12-18

Family

ID=69232628

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021503531A Active JP7399382B2 (ja) 2018-07-30 2019-07-12 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤
JP2023194827A Active JP7738046B2 (ja) 2018-07-30 2023-11-16 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023194827A Active JP7738046B2 (ja) 2018-07-30 2023-11-16 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤

Country Status (9)

Country Link
US (1) US20210315978A1 (https=)
EP (1) EP3829625A4 (https=)
JP (2) JP7399382B2 (https=)
KR (1) KR20210038618A (https=)
CN (1) CN112638407A (https=)
AU (1) AU2019315807B2 (https=)
CA (1) CA3107105A1 (https=)
TW (1) TWI831813B (https=)
WO (1) WO2020028011A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020081408A1 (en) 2018-10-18 2020-04-23 Merck Sharp & Dohme Corp. Formulations of anti-rsv antibodies and methods of use thereof
MX2021004928A (es) 2018-10-31 2021-06-08 Merck Sharp & Dohme Llc Cristales de anticuerpo anti-pd-1 humano y metodos de uso de los mismos.
EP4110370A4 (en) * 2020-03-30 2023-06-07 Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd. HUMAN PARATHYROID HORMONE (PTH) FORMULATIONS AND METHODS OF PRODUCING THEM
WO2025032376A1 (en) * 2023-08-04 2025-02-13 Precise Biopharma Pvt Ltd A room temperature stable solution for injection of abaloparatide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
EP1030658A1 (en) * 1997-10-14 2000-08-30 Eli Lilly And Company Method of building and maintaining bone
KR100700869B1 (ko) * 2005-06-03 2007-03-29 재단법인 목암생명공학연구소 Ｐｔｈ, 완충제 및 안정제를 포함하는 안정한 ｐｔｈ조성물
CN100553674C (zh) * 2007-02-02 2009-10-28 重庆科润生物医药研发有限公司 一种重组人甲状旁腺激素(1-84)药物组合物及其制备方法
EP2052736A1 (en) * 2007-10-26 2009-04-29 Nycomed Danmark ApS Parathyroid hormone formulations und uses thereof
JP2015504087A (ja) * 2012-01-20 2015-02-05 ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ 安定化ｐｔｈ製剤

Similar Documents

Publication Publication Date Title
ES2405994T3 (es) Soluciones estabilizadas de teriparatide
ES2533601T3 (es) Nueva composición que comprende glucagón
ES2363272T3 (es) Formulaciones de la hormona paratiroidea y utilizaciones de la misma.
JP2021532110A5 (https=)
JP6063877B2 (ja) ペプチド薬物の非経口注射用の安定な製剤
KR102327754B1 (ko) 안정한 펩티드 제형물 및 제조 방법
KR102018998B1 (ko) 신속-작용 인슐린 조성물
JP7738046B2 (ja) 組換えヒト副甲状腺ホルモンの安定性を向上させるための製剤
KR20140018798A (ko) 지속형 인슐린분비 펩타이드 결합체 액상 제제
US20200222508A1 (en) Glucagon-like peptide 1 (glp-1) receptor agonist compositions
EP3423042B1 (en) A lyophilised pharmaceutical formulation and its use
US20240293515A1 (en) Stable liquid formulations of glucagon-like peptide 1 or analogues thereof
KR102954604B1 (ko) 인간 부갑상선 호르몬(pth)의 제형 및 그 제조 방법
HK40050341A (en) Formulations for improved stability of recombinant human parathyroid hormone
US20230190880A1 (en) Formulations of Human Parathyroid Hormone (PTH) and Methods for Producing Same
RU2022128012A (ru) Жидкие составы белков, содержащие средства для снижения вязкости
JP2023507890A (ja) メシル酸ジヒドロエルゴタミン製剤およびその治療的送達のための事前充填注射器
WO2019040904A1 (en) STORAGE-STABLE FORMULAS OF SINCALIDE